Table 3.
Comparison of the glycolipid-related indicators between the normal blood glucose and PreDM group among the PXSK patients
| NDMPXSK n = 20 (Male: 9 Female: 11) |
PDMPXSK n = 20 (Male: 9 Female: 11) |
t / z | p | ||
|---|---|---|---|---|---|
| SBP (mmHg) | 112.10 ± 7.13 | 122.30 ± 11.50 | 3.371 | 0.002 | ** |
| DBP (mmHg) | 73.85 ± 6.08 | 77.85 ± 10.07 | 1.521 | 0.137 | n.s |
| FBG (mmol/L) | 5.40 ± 0.39 | 5.82 ± 0.66 | 1.458 | 0.153 | n.s |
| 2-h PG (mmol/L) | 5.57 ± 0.92 | 8.88 ± 1.26 | 9.489 | 0.001 | *** |
| HbA1c (%) | 4.76 ± 0.37 | 5.46 ± 0.49 | 5.100 | 0.001 | *** |
| FINS (μU/mL) | 8.04 ± 5.58 | 6.60 ± 3.92 | 0.944 | 0.351 | n.s |
| UA (mmol/L) | 363.90 ± 88.36 | 295.48 ± 104.47 | 2.236 | 0.031 | * |
| TG (mmol/L) | 1.33 ± 0.59 | 1.92 ± 1.48 | 1.660 | 0.106 | n.s |
| TC (mmol/L) | 4.63 ± 0.84 | 4.71 ± 1.05 | 0.266 | 0.792 | n.s |
| HDL-C (mmol/L) | 1.33 ± 0.28 | 1.65 ± 0.37 | 2.498 | 0.017 | * |
| LDL-C (mmol/L) | 2.78 ± 0.58 | 2.96 ± 0.84 | 0.789 | 0.435 | n.s |
| HOMA-IR | 1.91 ± 1.27 | 1.72 ± 1.09 | 0.508 | 0.615 | n.s |
| HOMA-IS | 0.68 ± 0.30 | 0.82 ± 0.49 | 1.090 | 0.283 | n.s |
| HOMA-β (%) | 93.40 ± 78.84 | 61.72 ± 42.87 | 1.579 | 0.123 | n.s |
SBP systolic blood pressure, DBP diastolic blood pressure, FBG fasting blood glucose, 2-h PG 2-hour post-load blood glucose, HbA1c glycosylated hemoglobin, FINS fasting insulin, UA uric acid, TG triglyceride, TC total cholesterol, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, HOMA-IR homeostatic model assessment for insulin resistance, HOMA-IS homeostatic model assessment for insulin sensibility, HOMA-β homeostatic model assessment of β-cell function. n.s. not significant, *p < 0.05, **p < 0.01, ***p < 0.001. The Mann–Whitney U test was used to test for significant differences between the groups, data are n (%) or mean ± SD